1. API ionic liquids: probing the effect of counterion structure on physical form and lipid solubility. Issue 22 (31st March 2020) Authors: Ford, Leigh; Tay, Erin; Nguyen, Tri-Hung; Williams, Hywel D.; Benameur, Hassan; Scammells, Peter J.; Porter, Christopher J. H. Journal: RSC advances Issue: Volume 10:Issue 22(2020) Page Start: 12788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Choice of Nonionic Surfactant Used to Formulate Type IIIA Self‐Emulsifying Drug Delivery Systems and the Physicochemical Properties of the Drug Have a Pronounced Influence on the Degree of Drug Supersaturation that Develops During In Vitro Digestion. Issue 4 (27th January 2014) Authors: Devraj, Ravi; Williams, Hywel D.; Warren, Dallas B.; Porter, Christopher J. H.; Pouton, Colin W. Journal: Journal of pharmaceutical sciences Issue: Volume 103:Issue 4(2014:Apr.) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dietary docosahexaenoic acid supplementation enhances expression of fatty acid‐binding protein 5 at the blood–brain barrier and brain docosahexaenoic acid levels. Issue 2 (30th July 2018) Authors: Pan, Yijun; Morris, Elonie R.; Scanlon, Martin J.; Marriott, Philip J.; Porter, Christopher J. H.; Nicolazzo, Joseph A. Journal: Journal of neurochemistry Issue: Volume 146:Issue 2(2018) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Frontispiece: Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability. Issue 44 (21st October 2016) Authors: Hu, Luojuan; Quach, Tim; Han, Sifei; Lim, Shea F.; Yadav, Preeti; Senyschyn, Danielle; Trevaskis, Natalie L.; Simpson, Jamie S.; Porter, Christopher J. H. Journal: Angewandte Chemie international edition Issue: Volume 55:Issue 44(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Frontispiz: Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability. (24th October 2016) Authors: Hu, Luojuan; Quach, Tim; Han, Sifei; Lim, Shea F.; Yadav, Preeti; Senyschyn, Danielle; Trevaskis, Natalie L.; Simpson, Jamie S.; Porter, Christopher J. H. Journal: Angewandte Chemie Issue: Volume 128:Number 44(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Gastric Pre‐Processing Is an Important Determinant of the Ability of Medium‐Chain Lipid Solution Formulations to Enhance Oral Bioavailability in Rats. Issue 11 (26th August 2013) Authors: Lee, Kathy Wai Yu; Porter, Christopher J. H.; Boyd, Ben J. Journal: Journal of pharmaceutical sciences Issue: Volume 102:Issue 11(2013:Nov.) Page Start: 3957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability. (2nd August 2016) Authors: Hu, Luojuan; Quach, Tim; Han, Sifei; Lim, Shea F.; Yadav, Preeti; Senyschyn, Danielle; Trevaskis, Natalie L.; Simpson, Jamie S.; Porter, Christopher J. H. Journal: Angewandte Chemie Issue: Volume 128:Number 44(2016) Page Start: 13904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Glyceride‐Mimetic Prodrugs Incorporating Self‐Immolative Spacers Promote Lymphatic Transport, Avoid First‐Pass Metabolism, and Enhance Oral Bioavailability. Issue 44 (2nd August 2016) Authors: Hu, Luojuan; Quach, Tim; Han, Sifei; Lim, Shea F.; Yadav, Preeti; Senyschyn, Danielle; Trevaskis, Natalie L.; Simpson, Jamie S.; Porter, Christopher J. H. Journal: Angewandte Chemie international edition Issue: Volume 55:Issue 44(2016) Page Start: 13700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lipid‐Based Formulations Solidified Via Adsorption onto the Mesoporous Carrier Neusilin® US2: Effect of Drug Type and Formulation Composition on In Vitro Pharmaceutical Performance. Issue 6 (16th April 2014) Authors: Williams, Hywel D.; Van Speybroeck, Michiel; Augustijns, Patrick; Porter, Christopher J. H. Journal: Journal of pharmaceutical sciences Issue: Volume 103:Issue 6(2014:Jun.) Page Start: 1734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimal PEGylation can Improve the Exposure of Interferon in the Lungs Following Pulmonary Administration. Issue 4 (28th January 2015) Authors: Mcleod, Victoria M.; Chan, Linda J.; Ryan, Gemma M.; Porter, Christopher J. H.; Kaminskas, Lisa M. Journal: Journal of pharmaceutical sciences Issue: Volume 104:Issue 4(2015:Apr.) Page Start: 1421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗